Dolutegravir (DTG) is a highly effective antiretroviral medication used in the treatment of HIV/AIDS. It belongs to the integrase inhibitor class of drugs, blocking the virus’s ability to integrate its genetic material into human cells, thereby preventing replication and slowing disease progression. DTG is widely recognized for its potency, minimal side effects, and convenient once-daily dosing regimen, making it a preferred treatment option for many individuals living with HIV. Sourcing Dolutegravir Globally The demand for Dolutegravir continues to grow worldwide, particularly in regions with high HIV prevalence. However, access to this medication can be challenging due to various factors, including supply chain disruptions, pricing variations, and regulatory hurdles. KENYA MEDICAL…